Dicyclomine Hydrochloride (Page 4 of 4)

16 HOW SUPPLIED/STORAGE AND HANDLING

Dicyclomine Hydrochloride Injection, USP, 10 mg/mL in 2 mL single dose vials, (for INTRAMUSCULAR use only, NOT FOR INTRAVENOUS USE) is supplied as follows:

NDC 0641-6173-10: boxes of 10 vials

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

Protect from freezing.

For Product Inquiry call 1-877-845-0689.

17 PATIENT COUNSELING INFORMATION

17.1 Inadvertent Intravenous Administration

Dicyclomine injection is for intramuscular administration only. Do not administer by any other route. Inadvertent administration may result in thrombosis or thrombophlebitis, and injection site reactions such as pain, edema, skin color change and even reflex sympathetic dystrophy syndrome [see Adverse Reactions (6.2)].

17.2 Use in Infants

Inform parents and caregivers not to administer dicyclomine in infants less than 6 months of age [see Use in Specific Populations (8.4)].

17.3 Use in Nursing Mothers

Advise lactating women that dicyclomine should not be used while breastfeeding their infants [see Use in Specific Populations (8.3, 8.4)].

17.4 Peripheral and Central Nervous System

In the presence of a high environmental temperature, heat prostration can occur with dicyclomine use (fever and heat stroke due to decreased sweating). If symptoms occur, the drug should be discontinued and a physician contacted. Dicyclomine may produce drowsiness or blurred vision. The patient should be warned not to engage in activities requiring mental alertness, such as operating a motor vehicle or other machinery or to perform hazardous work while taking dicyclomine [see Warnings and Precautions (5.3)].

Manufactured by:
Hikma Pharmaceuticals USA Inc.
Berkeley Heights, NJ 07922

Revised December 2019

462-718-02

PRINCIPAL DISPLAY PANEL

NDC 0641-6173 -01 Rx only
Dicyclomine
HCl Injection, USP
20 mg per 2 mL
(10 mg/mL)
IM use ONLY
Not for IV use2 mL Single Dose Vial

vial
(click image for full-size original)

NDC 0641-6173 -10 Rx only
Dicyclomine
HCl Injection, USP
20 mg per 2 mL
(10 mg/mL)

For Intramuscular use ONLY
Not for Intravenous use10 x 2 mL Single Dose Vials

sp
(click image for full-size original)

SERIALIZATION IMAGE

Layout 1Layout 1
DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0641-6173
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DICYCLOMINE HYDROCHLORIDE (DICYCLOMINE) DICYCLOMINE HYDROCHLORIDE 10 mg in 1 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0641-6173-10 10 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE (0641-6173-01)
1 NDC:0641-6173-01 2 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0641-6173-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040465 12/30/2015
Labeler — Hikma Pharmaceuticals USA Inc. (946499746)
Establishment
Name Address ID/FEI Operations
Hikma Pharmaceuticals USA Inc. 946499746 analysis (0641-6173), label (0641-6173), manufacture (0641-6173), pack (0641-6173)

Revised: 12/2019 Hikma Pharmaceuticals USA Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.